Evidence Hub

The Clinical Effect of Moxifloxacin for the Treatment of Community Acquired Pneumonia

Kuang Yaojun

Clinical Medical Engineering, 2011

120 participants

Abstract

Objective To explore the clinical effect of moxifloxacin in treatment of patients with community acquired pneumonia(CAP).Methods 120 cases of patients with community acquired pneumonia were randomly divided into the experimental group and control group.Azithromycin was used for the control group and moxifloxacin was used for the experimental group.Results The obvious effective rate of the experimental group was significantly higher than that of the control group(χ 2 = 6.065,P 0.05);the total effective rate of the experimental group was higher than that of the control group but had no significant difference(χ 2 = 2.743,P 0.05);the side-reaction rate of the experimental group was higher than that of the control group but had no significant difference(χ 2 = 0.093,P 0.05).Conclusions Moxifloxacin has better clinical effect in treatment of patients with community acquired pneumonia,which is a good choice for patients.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free